Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - Anthera Pharmaceuticals Inc | f58478exv32w2.htm |
| EX-31.1 - EX-31.1 - Anthera Pharmaceuticals Inc | f58478exv31w1.htm |
| EX-31.2 - EX-31.2 - Anthera Pharmaceuticals Inc | f58478exv31w2.htm |
| EX-23.1 - EX-23.1 - Anthera Pharmaceuticals Inc | f58478exv23w1.htm |
| EX-14.1 - EX-14.1 - Anthera Pharmaceuticals Inc | f58478exv14w1.htm |
| EX-10.42 - EX-10.42 - Anthera Pharmaceuticals Inc | f58478exv10w42.htm |
| EX-10.41 - EX-10.41 - Anthera Pharmaceuticals Inc | f58478exv10w41.htm |
| 10-K - FORM 10-K - Anthera Pharmaceuticals Inc | f58478e10vk.htm |
Exhibit 32.1
Certification Pursuant to
Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, and 18 U.S.C. Section 1350
Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, and 18 U.S.C. Section 1350
I, Paul F. Truex, certify, pursuant to the requirement set forth in Rule 13a-14(b) of the
Securities Exchange Act of 1934, as amended, and 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that the Annual Report of Anthera Pharmaceuticals,
Inc. on FORM 10-K for the fiscal year ended December 31, 2010 fully complies with the requirements
of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in
such Annual Report on FORM 10-K fairly presents, in all material respects, the financial condition
and results of operations of Anthera Pharmaceuticals, Inc.
| By: | /s/ Paul F. Truex | |||
| Name: | Paul F. Truex | |||
| Title: | President and Chief Executive Officer (Principal Executive Officer) |
|||
Date:
March 7, 2011